Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""psoriasis"" wg kryterium: Temat


Starter badań:

Tytuł:
Risk of infections among patients with psoriasis on Janus kinase inhibitor treatment: A systematic review and meta-analysis.
Autorzy:
Tarafdar N; Schulich School of Medicine & Dentistry, Department of Medicine, Western University, London, Ontario, Canada.
Sachdeva M; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Dubale NM; Schulich School of Medicine & Dentistry, Department of Medicine, Western University, London, Ontario, Canada.
Savinova I; Michael G. DeGroote School of Medicine, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Lytvyn Y; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Maliyar K; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Department of Dermatology, Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: .
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Mar; Vol. 90 (3), pp. 662-665. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Janus Kinase Inhibitors*/adverse effects
Psoriasis*/complications
Psoriasis*/drug therapy
Psoriasis*/chemically induced
Humans ; Protein Kinase Inhibitors/adverse effects ; Janus Kinases
Czasopismo naukowe
Tytuł:
Revolutionizing Psoriasis Topical Treatment: Enhanced Efficacy Through Ceramide/Phospholipid Composite Cerosomes Co-Delivery of Cyclosporine and Dithranol: In-Vitro, Ex-Vivo, and in-Vivo Studies.
Autorzy:
Elhabal SF; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Mokattam, Cairo, Egypt.
Abdelaal N; Department of Integrative Physiology, Baylor College of Medicine, Houston, TX, USA.
Al-Zuhairy SAS; Department of Pharmacy, Kut University College, Kut, Wasit, Iraq.
Mohamed Elrefai MF; Department of Anatomy, Histology, Physiology, and Biochemistry, Faculty of Medicine, The Hashemite University, Zarqa, Jordan.; Department of Anatomy and Embryology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Khalifa MM; Department of Human Physiology, Faculty of Medicine, Cairo University, Cairo, Egypt.
Khasawneh MA; Department of Chemistry, College of Science, U.A.E. University, Al-Ain, United Arab Emirates.
Elsaid Hamdan AM; Department of Pharmacy Practice, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia.
Mohie PM; Department of Clinical Pharmacology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Gad RA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Nahda University, Beni-Suef, Egypt.
Kabil SL; Department of Clinical Pharmacology, Faculty of Medicine, Zagazig University, Zagazig, Egypt.
El-Ashery MK; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.; Medicinal Chemistry Department, Faculty of Pharmacy, King Salman International University, Ras-Sedr, South Sinai, Egypt.
Jasti BR; Department of Pharmaceutics and Medicinal Chemistry, Thomas J. Long School of Pharmacy & Health Sciences, University of the Pacific, Stockton, CA, USA.
Elzohairy NA; Air Force Specialized Hospital, Cairo, Egypt.; Department of Microbiology and Immunology, Faculty of Pharmacy, Modern University for Technology and Information (MTI), Mokattam, Cairo, Egypt.
Elfar N; Department of Pharmaceutical Technology, Faculty of Pharmacy, Horus University, New Demiette, Egypt.
Elnawawy T; Department of Pharmaceutics, Egyptian Drug Authority, Cairo, Egypt.
Hassan FE; Medical Physiology Department, Kasr Alainy, Faculty of Medicine, Cairo University, Giza, Egypt.; General Medicine Practice Program, Department of Physiology, Batterjee Medical College, Jeddah, Saudi Arabia.
El-Nabarawi MA; Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Pokaż więcej
Źródło:
International journal of nanomedicine [Int J Nanomedicine] 2024 Feb 07; Vol. 19, pp. 1163-1187. Date of Electronic Publication: 2024 Feb 07 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Anthralin*/pharmacology
Anthralin*/therapeutic use
Psoriasis*/drug therapy
Psoriasis*/pathology
Humans ; Animals ; Mice ; Cyclosporine/pharmacology ; Phospholipids ; Ceramides/pharmacology ; Administration, Cutaneous ; Skin ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
Association between several immune response-related genes and the effectiveness of biological treatments in patients with moderate-to-severe psoriasis.
Autorzy:
Loras A; Department of Medicine, Jaume I University of Castellon, Castello de la Plana, Spain.; Department of Surgery, University of Valencia, Valencia, Spain.
Gil-Barrachina M; Department of Medicine, Jaume I University of Castellon, Castello de la Plana, Spain.
Hernando B; Computational Oncology Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Perez-Pastor G; Department of Dermatology, Valencia General University Hospital, Valencia, Spain.
Martinez-Domenech A; Department of Dermatology, Valencia General University Hospital, Valencia, Spain.
Mahiques L; Department of Dermatology, Castellon General University Hospital, Castello de la Plana, Spain.
Pitarch G; Department of Dermatology, Castellon General University Hospital, Castello de la Plana, Spain.
Valcuende-Cavero F; Department of Dermatology, La Plana Hospital, Vila-real, Spain.
Ballester-Sanchez R; Department of Dermatology, La Plana Hospital, Vila-real, Spain.
Marques-Torrejon MA; Department of Medicine, Jaume I University of Castellon, Castello de la Plana, Spain.
Martinez-Cadenas C; Department of Medicine, Jaume I University of Castellon, Castello de la Plana, Spain.
Pokaż więcej
Źródło:
Experimental dermatology [Exp Dermatol] 2024 Jan; Vol. 33 (1), pp. e15003.
Typ publikacji:
Journal Article
MeSH Terms:
Tumor Necrosis Factor-alpha*/genetics
Psoriasis*/drug therapy
Psoriasis*/genetics
Humans ; Interleukin-12/genetics ; Polymorphism, Single Nucleotide ; Tumor Necrosis Factor Inhibitors/therapeutic use ; Treatment Outcome ; Immunity ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
The ameliorative effects of topical gemifloxacin alone or in combination with clobetasol propionate on imiquimod-induced model of psoriasis in mice.
Autorzy:
Salman HR; Department of Pharmacology, College of Pharmacy, Al-Mustaqbal University, 510001, Hillah, Babylon, Iraq. .; Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq. .
Al-Zubaidy AA; Department of Pharmacology, College of Medicine, University of Warith Al-Anbiyaa, Karbala, Iraq.
Abbas AH; Department of Pharmacology, College of Medicine, Al-Nahrain University, Baghdad, Iraq.
Zigam QA; Department of Pharmacology, College of Pharmacy, Al-Mustaqbal University, 510001, Hillah, Babylon, Iraq.
Pokaż więcej
Źródło:
Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2024 Jan; Vol. 397 (1), pp. 599-616. Date of Electronic Publication: 2023 Jul 25.
Typ publikacji:
Journal Article
MeSH Terms:
Clobetasol*/therapeutic use
Clobetasol*/pharmacology
Psoriasis*/chemically induced
Psoriasis*/drug therapy
Animals ; Mice ; Imiquimod/adverse effects ; Gemifloxacin/adverse effects ; NF-kappa B ; Glia Maturation Factor/pharmacology ; Skin ; Cytokines ; Anti-Inflammatory Agents/pharmacology ; Anti-Inflammatory Agents/therapeutic use ; Disease Models, Animal ; Mice, Inbred BALB C
Czasopismo naukowe
Tytuł:
Psoriasis Severity, Health-Related Quality of Life, Work Productivity, and Activity Impairments Among Patients With Moderate to Severe Psoriasis Receiving Systemic Treatment: Real-World Data From Clinical Practice in Spain.
Autorzy:
Daudén E; Dermatology Department, IIS-IP, Hospital Universitario La Princesa, Madrid, Spain.
Vidal D; Dermatology Department, Hospital Moisés Broggi, Barcelona, Spain.
Romero A; Dermatology Department, Hospital de Fuenlabrada, Madrid, Spain.
Bordel MT; Dermatology Department, Hospital Provincial de Zamora, Zamora, Spain.
Rivera R; Dermatology Department, Hospital Universitario 12 de Octubre, Madrid, Spain.
Márquez J; Dermatology Department, Hospital Universitario de Jerez de la Frontera, Jerez de la Frontera, Spain.
Zamora E; Dermatology Department, Hospital Universitario de Móstoles, Madrid, Spain.
Martinez L; Dermatology Department, Hospital Regional Universitario de Málaga, Málaga, Spain.
Ocaña MJ; Dermatology Department, Hospital Universitario San Agustín de Linares, Jaén, Spain.
Vila C; Dermatology Department, Hospital Universitario Juan Ramón Jiménez, Huelva, Spain.
Iribarren P; Medical Department, AbbVie Spain, S.L.U., Madrid, Spain.
Corona N; Medical Department, AbbVie Spain, S.L.U., Madrid, Spain.
Zulaica A; Dermatology Department, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain. Electronic address: .
Pokaż więcej
Źródło:
Actas dermo-sifiliograficas [Actas Dermosifiliogr] 2024 Jan; Vol. 115 (1), pp. 1-9. Date of Electronic Publication: 2023 Jul 08.
Typ publikacji:
Journal Article
MeSH Terms:
Quality of Life*
Psoriasis*/complications
Psoriasis*/drug therapy
Humans ; Adolescent ; Young Adult ; Adult ; Middle Aged ; Aged ; Spain/epidemiology ; Cross-Sectional Studies ; Skin ; Severity of Illness Index ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Cyclin-Dependent kinase 9 (CDK9) inhibitor Atuveciclib ameliorates Imiquimod-Induced Psoriasis-Like dermatitis in mice by inhibiting various inflammation factors via STAT3 signaling pathway.
Autorzy:
Zhao F; School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Wang Y; School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Zuo H; School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Ru Y; School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China.
Wang Y; School of Pharmacy, Anhui University of Chinese Medicine, Hefei 230012, China; Department of Medicinal Chemistry, Anhui Academy of Chinese Medicine, Hefei 230012, China. Electronic address: .
Pokaż więcej
Źródło:
International immunopharmacology [Int Immunopharmacol] 2024 Mar 10; Vol. 129, pp. 111652. Date of Electronic Publication: 2024 Feb 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Psoriasis*/chemically induced
Psoriasis*/drug therapy
Skin Diseases*
Dermatitis*
Sulfonamides*
Triazines*
Animals ; Mice ; Imiquimod/pharmacology ; STAT3 Transcription Factor/metabolism ; Cyclin-Dependent Kinase 9 ; Inflammation/chemically induced ; Signal Transduction ; Cytokines/metabolism
Czasopismo naukowe
Tytuł:
Risankizumab, a therapeutic alternative for psoriasis in people living with HIV.
Autorzy:
Estevinho T; Hospital do Divino Espírito Santo, Ponta Delgada, Portugal.
Freitas E; Department of Dermatology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.
Torres T; Department of Dermatology, Centro Hospitalar Universitário de Santo António, Porto, Portugal.; Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
Pokaż więcej
Źródło:
The Journal of international medical research [J Int Med Res] 2024 Mar; Vol. 52 (3), pp. 3000605241229324.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Psoriasis*/complications
Psoriasis*/drug therapy
HIV Infections*/complications
HIV Infections*/drug therapy
Antibodies, Monoclonal*
Humans ; HIV ; Interleukin-23
Czasopismo naukowe
Tytuł:
Exploration of the causality of frailty index on psoriasis: A Mendelian randomization study.
Autorzy:
Lei H; Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Xing Z; Department of Infectious Diseases, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Chen X; State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, National Clinical Research Center for Oral Diseases, Shaanxi Clinical Research Center for Oral Diseases, Department of Orthodontics, School of Stomatology, The Fourth Military Medical University, Xi'an, China.
Dai Y; Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Cheng B; Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wang S; Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Kang T; Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wang Q; Department of Dermatology, Tangdu Hospital, Air Force Military Medical University, Xi'an, China.
Zhang J; Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Jia J; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Department of Dermatology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.; Department of Dermatology,Guangdong Provincial Key Laboratory of Chinese Medicine for Prevention and Treatment of Refractory Chronic Disease, Guangzhou, China.
Zheng Y; Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Pokaż więcej
Źródło:
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2024 Mar; Vol. 30 (3), pp. e13641.
Typ publikacji:
Journal Article
MeSH Terms:
Frailty*
Psoriasis*/epidemiology
Psoriasis*/genetics
Humans ; Genome-Wide Association Study ; Mendelian Randomization Analysis
Czasopismo naukowe
Tytuł:
Does the risk of basal cell carcinoma increase in patients with psoriasis under treatment?
Autorzy:
Sevdem GA; Bezmialem Vakif University, Fatih/İstanbul, Turkey.
Ozlem KS; Bezmialem Vakif University, Fatih/İstanbul, Turkey.
Nazan Y; Bezmialem Vakif University, Fatih/İstanbul, Turkey.
Nahide O; Bezmialem Vakif University, Fatih/İstanbul, Turkey.
Pokaż więcej
Źródło:
Photodermatology, photoimmunology & photomedicine [Photodermatol Photoimmunol Photomed] 2024 Mar; Vol. 40 (2), pp. e12956.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Psoriasis*/pathology
Carcinoma, Basal Cell*/epidemiology
Ultraviolet Therapy*
Humans ; Adult ; Middle Aged ; Aged ; Undertreatment ; PUVA Therapy
Czasopismo naukowe
Tytuł:
The causal relationship between psoriasis and chronic obstructive pulmonary disease: A bidirectional mendelian randomization study.
Autorzy:
Liu M; Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhou X; Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zhang G; Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Liu L; College of Medicine, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Fang C; Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Li Z; Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zheng Y; Department of Dermatology, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Pokaż więcej
Źródło:
Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) [Skin Res Technol] 2024 Mar; Vol. 30 (3), pp. e13629.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/epidemiology
Psoriasis*/genetics
Pulmonary Disease, Chronic Obstructive*/epidemiology
Pulmonary Disease, Chronic Obstructive*/genetics
Humans ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Reproducibility of Results
Czasopismo naukowe
Tytuł:
Protective effect and regulatory mechanism of salidroside on skin inflammation induced by imiquimod in psoriasis mice.
Autorzy:
Su Z; Department of Dermatology, First Hospital of Shanxi Medical University, Taiyuan, China. Electronic address: zhenxing_.
Kang Y; Department of Thyroid Surgery, First Hospital of Shanxi Medical University, Taiyuan, China.
Pokaż więcej
Źródło:
Journal of pharmacological sciences [J Pharmacol Sci] 2024 Mar; Vol. 154 (3), pp. 192-202. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/chemically induced
Psoriasis*/drug therapy
Psoriasis*/genetics
MicroRNAs*/metabolism
Phenols*
Mice ; Animals ; Imiquimod/adverse effects ; Imiquimod/metabolism ; Skin ; Glucosides/adverse effects ; Inflammation/metabolism ; Mice, Inbred BALB C ; Disease Models, Animal
Czasopismo naukowe
Tytuł:
Association of antihypertensive drugs with psoriasis: A trans-ancestry and drug-target Mendelian randomization study.
Autorzy:
Xu X; Department of Nursing, Nantong Health College of Jiangsu Province, Nantong, China. Electronic address: .
Wang SY; Academic Affair Office, Nantong Vocational University, Nantong, China; Department of Postgraduate, St. Paul University Philippines, Tuggegarau, Philippines. Electronic address: .
Wang R; School of Nursing, Zhejiang Chinese Medical University, Hangzhou, China. Electronic address: .
Wu LY; College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China. Electronic address: .
Yan M; Department of Epidemiology, School of Public Health, Changzhou University, Changzhou, China; Faculty of Health and Welfare, Satakunta University of Applied Sciences, Pori, Finland. Electronic address: .
Sun ZL; Department of Rheumatology, School of Nursing, Nanjing University of Chinese Medicine, Nanjing, China. Electronic address: .
Sun QH; School of Nursing, Zhejiang Chinese Medical University, Hangzhou, China. Electronic address: .
Pokaż więcej
Źródło:
Vascular pharmacology [Vascul Pharmacol] 2024 Mar; Vol. 154, pp. 107284. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Antihypertensive Agents*/adverse effects
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Humans ; Mendelian Randomization Analysis ; Genome-Wide Association Study ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in Japanese patients with moderate to severe plaque, erythrodermic, or generalized pustular psoriasis: Efficacy and safety results from an open-label, phase 3 trial.
Autorzy:
Imafuku S; Department of Dermatology, Fukuoka University Faculty of Medicine, Fukuoka, Japan.
Okubo Y; Department of Dermatology, Tokyo Medical University, Tokyo, Japan.
Tada Y; Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.
Ohtsuki M; Department of Dermatology, Jichi Medical University, Tochigi, Japan.
Colston E; Bristol Myers Squibb, Princeton, New Jersey, USA.
Napoli A; Bristol Myers Squibb, Princeton, New Jersey, USA.
Shao Y; Bristol Myers Squibb, Princeton, New Jersey, USA.
Banerjee S; Bristol Myers Squibb, Princeton, New Jersey, USA.
Morita A; Department of Geriatrics and Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Pokaż więcej
Źródło:
The Journal of dermatology [J Dermatol] 2024 Mar; Vol. 51 (3), pp. 365-379. Date of Electronic Publication: 2024 Jan 24.
Typ publikacji:
Clinical Trial, Phase III; Journal Article
MeSH Terms:
Psoriasis*/drug therapy
Psoriasis*/chemically induced
Exanthema*/drug therapy
Skin Diseases, Vesiculobullous*/drug therapy
Heterocyclic Compounds*
Adult ; Humans ; Japan ; TYK2 Kinase/therapeutic use ; Antibodies, Monoclonal, Humanized/therapeutic use ; Treatment Outcome ; Severity of Illness Index ; Chronic Disease ; Acute Disease ; Double-Blind Method
Czasopismo naukowe
Tytuł:
Unmet needs in the management of psoriasis in Latin America: a systematic review.
Autorzy:
Ossanai Schoenardie B; Department of Dermatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil. Electronic address: .
Oliveira Almeida R; Department of Dermatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Hanemann T; Department of Dermatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Ossanai Schoenardie A; School of Medicine, Universidade Federal de Santa Maria, Santa Maria, RS, Brazil.
Ribeiro AL; Department of Rheumatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Catucci Boza J; Department of Dermatology, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.
Pokaż więcej
Źródło:
Anais brasileiros de dermatologia [An Bras Dermatol] 2024 Mar-Apr; Vol. 99 (2), pp. 244-258. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:
Systematic Review; Journal Article
MeSH Terms:
Psoriasis*/epidemiology
Psoriasis*/therapy
Humans ; Latin America/epidemiology ; Brazil/epidemiology
Czasopismo naukowe
Tytuł:
Cumulative life course impairment in patients with dermatological diseases, with a focus on psoriasis.
Autorzy:
Romiti R; Department of Dermatology, Hospital das Clínicas, Universidade de São Paulo, SP, Brazil. Electronic address: .
Magalhães RF; Discipline of Dermatology, Faculty of Medical Sciences, Universidade Estadual de Campinas, SP, Brazil.
Duarte GV; Instituto Bahiano de Imunoterapias, Salvador, BA, Brazil.
Pokaż więcej
Źródło:
Anais brasileiros de dermatologia [An Bras Dermatol] 2024 Mar-Apr; Vol. 99 (2), pp. 269-276. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Journal Article
MeSH Terms:
Quality of Life*
Psoriasis*/complications
Psoriasis*/psychology
Humans ; Cost of Illness ; Life Change Events ; Adaptation, Psychological ; Chronic Disease
Czasopismo naukowe
Tytuł:
Iranian psoriasis registry: Research protocol and preliminary results of a pilot study.
Autorzy:
Robati RM; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pourani MR; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Sadeghi Z; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mardani G; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Hasanzadeh S; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Moravvej H; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Nasiri S; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Namazi N; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Dadkhahfar S; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gheisari M; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Shahidi Dadras M; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ghalamkarpour F; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abdollahimajd F; Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Department of Dermatology, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.; Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Pokaż więcej
Źródło:
Journal of cosmetic dermatology [J Cosmet Dermatol] 2024 Mar; Vol. 23 (3), pp. 1004-1008. Date of Electronic Publication: 2023 Nov 06.
Typ publikacji:
Journal Article
MeSH Terms:
Psoriasis*/drug therapy
Psoriasis*/epidemiology
Male ; Female ; Child ; Humans ; Adult ; Iran/epidemiology ; Pilot Projects ; Registries
Czasopismo naukowe
Tytuł:
Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis.
Autorzy:
Zhang L; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Su Y; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Shucheng H; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Wang L; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Jiang X; Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China; Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Mar; Vol. 90 (3), pp. 646-648. Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Scalp*
Psoriasis*/drug therapy
Humans ; Network Meta-Analysis
Czasopismo naukowe
Tytuł:
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS).
Autorzy:
Warren RB; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom. Electronic address: .
French LE; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilian University Munich, Munich, Germany; Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.
Blauvelt A; Oregon Medical Research Center, Portland, Oregon.
Langley RG; Division of Dermatology, Dalhousie University, Halifax, Canada.
Egeberg A; Department of Dermatology, Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Mrowietz U; Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany.
Hunter HJA; Dermatology Centre, Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom; NIHR Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom; Medicines Evaluation Unit, Manchester, United Kingdom.
Gooderham M; SKiN Centre for Dermatology, Peterborough, Canada; Department of Medicine, Queen's University, Kingston, Canada.
Soerensen P; UNION Therapeutics A/S, Hellerup, Denmark.
Andres P; UNION Therapeutics A/S, Hellerup, Denmark.
Sommer MOA; UNION Therapeutics A/S, Hellerup, Denmark; Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark.
Carlsson A; UNION Therapeutics A/S, Hellerup, Denmark.
Kjøller KD; UNION Therapeutics A/S, Hellerup, Denmark.
Strober BE; Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut; Central Connecticut Dermatology Research, Cromwell, Connecticut.
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Mar; Vol. 90 (3), pp. 494-503. Date of Electronic Publication: 2023 Nov 10.
Typ publikacji:
Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Phosphodiesterase 4 Inhibitors*/adverse effects
Adult ; Humans ; Treatment Outcome ; Severity of Illness Index ; Double-Blind Method
Czasopismo naukowe
Tytuł:
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial.
Autorzy:
Merola JF; Division of Rheumatology, Department of Dermatology and Department of Medicine and Associate Program Director, Combined Medicine-Dermatology Residency Program, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: .
Parish LC; President, Paddington Testing Company, Inc, Philadelphia, Pennsylvania.
Guenther L; Guenther Research Inc, London, Ontario, Canada.
Lynde C; Chief Medical Director, Lynde Institute for Dermatology, Markham, Ontario, Canada; Probity Medical Research, Markham, Ontario, Canada.
Lacour JP; Department of Dermatology, CHU de Nice - Hôpital l'Archet, Nice, France.
Staubach P; Department of Dermatology, University Medical Center, Mainz, Germany.
Cheng S; Global Development, Amgen Inc, Thousand Oaks, California.
Paris M; Global Patient Safety, Amgen Inc, Thousand Oaks, California.
Picard H; Global Development, Amgen Inc, Thousand Oaks, California.
Deignan C; Medical Affairs, Amgen Inc, Thousand Oaks, California.
Jardon S; Medical Affairs, Amgen Inc, Thousand Oaks, California.
Chen M; Global Development, Amgen Inc, Thousand Oaks, California.
Papp KA; Alliance Clinical Trials and Probity Medical Research, Waterloo, Ontario, Canada; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Mar; Vol. 90 (3), pp. 485-493. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Quality of Life*
Psoriasis*/diagnosis
Psoriasis*/drug therapy
Psoriasis*/chemically induced
Thalidomide/*analogs & derivatives
Humans ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Severity of Illness Index ; Double-Blind Method ; Genitalia ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Obstructive sleep apnea among patients with psoriasis: A case-control study in the All of Us Research Program.
Autorzy:
Shaw VR; Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
Tobias LA; Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut; Section of Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, Connecticut.
Cohen JM; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut; Section of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut. Electronic address: .
Pokaż więcej
Źródło:
Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Mar; Vol. 90 (3), pp. 666-668. Date of Electronic Publication: 2023 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Population Health*
Sleep Apnea, Obstructive*/complications
Sleep Apnea, Obstructive*/epidemiology
Psoriasis*/complications
Psoriasis*/epidemiology
Humans ; Case-Control Studies ; Patients ; Quality of Life
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies